Ultragenyx Pharmaceutical Inc.RARENASDAQ
Loading
Asset Growth Recovery in ProgressRecovering
Percentile Rank57
3Y CAGR+7.8%
5Y CAGR-49.0%
Studio
Year-over-Year Change

Year-over-year total asset growth rate

3Y CAGR
+7.8%/yr
vs -57.6%/yr prior
5Y CAGR
-49.0%/yr
Recent acceleration
Acceleration
+65.4pp
Accelerating
Percentile
P57
Within normal range
vs 5Y Ago
0x
Contraction
Streak
2 yr
Consecutive growthRecovering
PeriodValue
20251.90%
20240.83%
2023-3.52%
20221.51%
2021-13.48%
202054.96%
201957.80%
201846.62%
2017-9.23%
2016-3.39%